AF
BNGO icon

Advisornet Financial’s Bionano Genomics BNGO Stock Holding History

Advisornet Financial’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$1 – 2200
2024
Q2 		– Hold
0
– – – 2077
2024
Q1 		– Hold
0
– -$19 – 2096
2023
Q4 		– Hold
0
– – – 2419
2020
Q3 		– Sell
-3
Closed -$1K – 1734
2020
Q2 		$1K Hold
3
– – ﹤0.01% 1649
2020
Q1 		$1K Buy
+3
New +$1.69K ﹤0.01% 1640

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

Advisornet Financial's BNGO Position: Q3 2024 in Review

Advisornet Financial held its Bionano Genomics (BNGO) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Advisornet Financial first reported a position in BNGO in Q1 2020 and has held it in 2 quarters since. The position peaked at $1K in Q2 2020. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Advisornet Financial held 0 shares of Bionano Genomics worth $0 as of Q3 2024.
  • Advisornet Financial left its Bionano Genomics share count unchanged in Q3 2024.
  • Bionano Genomics made up ﹤0.01% of Advisornet Financial's portfolio in Q3 2024, its #2200 holding.
  • Advisornet Financial first reported a position in Bionano Genomics in Q1 2020 and has held it in 2 quarters since.
  • Advisornet Financial's Bionano Genomics position peaked at $1K in Q2 2020.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Advisornet Financial's 13F filing for Q3 2024, filed 15 Oct 2024.